General Information of the Compound
Compound ID |
CP0310616
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-Aryloxy-4-alkylaminopyridine, 3a
Show/Hide
|
||||||||||||||||||
Synonyms |
175140-00-8
1Q5
2-Aryloxy-4-alkylaminopyridine, 3a
3,6-Dimethyl-N-(Pentan-3-Yl)-2-(2,4,6-Trimethylphenoxy)pyridin-4-Amine
4-Pyridinamine, N-(1-ethylpropyl)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)-
4k5y
5113G7FP34
AKOS015994585
API0007847
BDBM20966
CHEMBL270948
CP 376,395
CP 376395
CP-376,395
CP-376395
CP376395
CS-7833
DTXSID0047298
GD-0065
GTPL3496
HY-14130
KB-76174
KS-00002WT7
MolPort-009-194-134
SCHEMBL123421
UNII-5113G7FP34
VIZBSVDBNLAVAW-UHFFFAOYSA-N
ZINC14975027
compound 3a [PMID: 18288792]
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C21H30N2O
|
||||||||||||||||||
Molecular Weight |
326.484
|
||||||||||||||||||
Canonical SMILES |
CCC(CC)Nc1cc(C)nc(Oc2c(C)cc(C)cc2C)c1C
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H30N2O/c1-8-18(9-2)23-19-12-16(6)22-21(17(19)7)24-20-14(4)10-13(3)11-15(20)5/h10-12,18H,8-9H2,1-7H3,(H,22,23)
Show/Hide
|
||||||||||||||||||
InChIKey |
VIZBSVDBNLAVAW-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound